Macquarie analyst Eugene Hsiao changed the firm's stance on Li Auto (NASDAQ:LI), upgrading the stock from Neutral to Outperform with a price target (PT) of $29.00. The adjustment follows the company's ...

Investing.com-- Macquarie upgraded Li Auto Inc (NASDAQ:LI) to outperform despite the company likely missing its Q4 guide, as it sees lower risk at current price levels. The US listed stock rose more ...

Alibaba's AI advancements and promising financial growth make it a compelling stock with significant upside potential. Read ...

Ford CEO Jim Farley warns that with Trump's tariffs we could see "billions of billions of dollars of pressure on the industry, lost jobs, lots of impacts to communities and our ecosystem in the ...

Macquarie upgraded Li Auto (LI) to Outperform from Neutral.Maximize Your Portfolio with Data Driven Insights:Leverage the power of TipRanks' ...

Li Auto (LI) shares were up more than 6.7% in Thursday trade after investment group Macquarie upgraded the stock from ‘neutral’ to ‘outperform’. Electric vehicl ...

Holocene Advisors LP boosted its position in Microsoft Co. (NASDAQ:MSFT – Free Report) by 1,154.3% during the third quarter, ...

KBC Group NV raised its stake in shares of StepStone Group LP (NASDAQ:STEP – Free Report) by 64.8% in the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 3,032 ...

Eli Lilly stock is higher Thursday after the pharma giant beat fourth-quarter profit expectations and issued strong 2025 ...

Weight loss drugs are huge these days, and Eli Lilly (LLY) is leading the pack when it comes to these. However, today’s ...

Meta, Microsoft, and Google parent Alphabet are expecting a cumulative $228 billion in capital expenditures in 2025, driven ...

Eli Lilly, the world’s biggest drugmaker by market value, reported higher-than-expected quarterly profit and issued a bullish earnings forecast. Sales of weight-loss drug Zepbound and diabetes drug ...